Human Granzyme B ELISPOT Kit (with un-coated plates)
Human Granzyme B ELISPOT Kit (with un-coated plates)
Be the first to review this product! Submit a review
|
(1 Publication)
Human Granzyme B ELISPOT Kit (with un-coated plates) is a ELISPOT kit for the sensitive detection of Human Granzyme B (with un-coated plates) production in a single cell suspension.
別名を表示する
CGL1, CSPB, CTLA1, GRB, GZMB, Granzyme B, C11, CTLA-1, Cathepsin G-like 1, Cytotoxic T-lymphocyte proteinase 2, Fragmentin-2, Granzyme-2, Human lymphocyte protein, SECT, T-cell serine protease 1-3E, CTSGL1, Lymphocyte protease, HLP
- ELISPOT
PubMed
ELISPOT - Human Granzyme B ELISPOT Kit (with un-coated plates) (AB46617)
Measurement of Granzyme B release from Human NK cells using ab46617 - Granzyme B Human Elispot Kit.
NK cells were cultured with rIL-2 and with/without TKD peptide (2 µg/ml) for 4–5 days prior to stimulation with i/uRBC (1 : 3 or 10 : 1), before being isolated. Granzyme B release was determined via ELISPOT assay following the protocol, with 2000 effector cells. Experiments were repeated using a blocking antibody directed against Hsp70.
Image from Böttger E et al., PLoS One. 2012;7(3) : e33774. doi : 10.1371/journal.pone.0033774. Epub 2012 Mar 15.; Fig 6.; March 15, 2012, PLoS ONE 7(3) : e33774.
Böttger E et al., PLoS One, 7, e33774, 2012 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
Reactivity data
製品の詳細
This Human Granzyme B ELISPOT Kit (with un-coated plates) is designed to enumerate Granzyme B producing cells in a single cell suspension. This method has the advantage of requiring a minimum of in-vitro manipulations allowing Granzyme B production analysis as close as possible to in-vivo conditions in a highly specific way. This technique is designed to determine the frequency of Granzuyme B producing cells under a given stimulation, and the follow-up of such frequency during a treatment and/or a pathological state. ELISPOT assay constitutes an ideal tool in the TH1 / TH2 response, vaccine development, viral infection monitoring and treatment, cancerology, infectious diseases, autoimmune diseases and transplantation.
The ELISPOT assay is based on sandwich immuno-enzyme technology. Cell secreted cytokines or soluble molecules are captured by coated antibodies avoiding diffusion in supernatant, protease degradation or binding on soluble membrane receptors. After cell removal, the captured cytokines are revealed by tracer antibodies and appropriate conjugates.
Principle of Method
After cell stimulation, locally produced cytokines are captured by a specific monoclonal antibody. After cell lysis, trapped cytokine molecules are revealed by a secondary biotinylated detection antibody, which is in turn recognised by streptavidin conjugated to alkaline phosphatase. PVDF-bottomed-well plates are then incubated with BCIP/NBT substrate. Colored "purple" spots indicate cytokine production by individual cells.
Recognizes natural human Granzyme B.
製品内容
出荷温度及び保存条件
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Granzyme B participates prominently in the immune response by activating caspases particularly caspase-3 which promotes the breakdown of cellular components necessary for apoptosis. Granzyme B does not function in isolation but acts in concert with other immune system factors such as perforin to effectively induce cell death. Perforin creates pores in the target cell membrane allowing granzyme B to enter and instigate the apoptosis sequence. The enzyme also contributes to the processing of cytokines which enhances the immune response further.
Pathways
Studies have determined that granzyme B is critical in the apoptosis pathway particularly in the granule exocytosis pathway. It closely interacts with proteins such as perforin and other granzymes to mediate apoptosis in target cells. Granzyme B also plays a role in the inflammatory response and can influence pathways associated with cytotoxic T cell signaling. Its pathway interactions ensure effective elimination of damaged or infected cells maintaining tissue homeostasis.
ターゲットの情報
文献 (1)
Recent publications for all applications. Explore the full list and refine your search
PloS one 7:e33774 PubMed22438997
2012
Applications
ELISPOT
Species
Human
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com